BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...

BioNTech adds bispecific candidate, mRNA delivery startup as cancer work takes center stage The opportunity is enormous: ...

BioNTech SE (BNTX) announced Tuesday that it has signed an agreement to acquire Biotheus, a clinical-stage biotechnology company ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

BioNTech said the combination aimed to enable the immune system ... “We are committed to advancing its research and ...

The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...

This partnership actually started in 2018 when Pfizer wanted to access BioNTech's research and development regarding mRNA flu ...

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...